article thumbnail

Flu Vaccines Are a Go

Pharmacy Times

Votes are cast and recommendations made, none of which bind the CDC or the US Department of Health and Human Services (HHS), though it is rare for the CDC not to follow ACIP’s recommendations. 2 Recently, all 17 members of the existing ACIP committee were removed by the HHS Secretary Robert F.

article thumbnail

NCPA Laments SCOTUS Decision to Punt on Oklahoma PBM Reform

Pharmacy Times

PCMA unanimous Supreme Court decision in 2020, which allowed states to regulate PBMs, the big health insurance companies and their PBM lobby have been barnstorming the country putting up one legal challenge after another.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Pharmalittle: We’re reading about an Italian acquisition, Medicare Advantage market growth, and more

STAT

  Italian pharma company Recordati said it will buy from Sanofi the global rights to an approved drug to treat cold agglutinin disease , a rare autoimmune disorder, for $825 million, Reuters reports.    The Medicare Advantage market is expected to grow in 2025, despite big changes from insurers , STAT reports.

article thumbnail

Is Livongo-Teladoc merger a ‘leap forward’ for digital health?

pharmaphorum

While both companies operate in virtual care and chronic condition management, their approaches are very different. Its second-quarter revenue leaped 125% to almost $92 million.

article thumbnail

Express Scripts on the Road to Damascus?

Ramblings of a pharmacist

It’s a very useful metric for chronic diabetes management, because since red blood cells stick around in the blood for ~3 months, it can give you a sense of how well controlled a person’s diabetes is over the past three months, even if their current blood sugar is perfectly normal. They do… to a point.